{
  "id": "doc:fda.revuforj",
  "type": "Document",
  "subtype": "Regulatory approval",
  "name": "Revuforj (revumenib) [package insert]. FDA.",
  "aliases": null,
  "citation": "Syndax Pharmaceuticals, Inc. Revuforj (revumenib) [package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218944s000lbl.pdf. Revised November 2024. Accessed January 10, 2025.",
  "company": "Syndax Pharmaceuticals, Inc.",
  "drug_name_brand": "Revuforj",
  "drug_name_generic": "revumenib",
  "first_published": "2024-11-15",
  "access_date": "2025-01-10",
  "organization_id": "fda",
  "publication_date": "2024-11-15",
  "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218944s000lbl.pdf",
  "url_drug": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218944",
  "application_number": 218944
}